BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
Polypectomy decreases colorectal cancer (CRC) incidence and mortality. 19% of post-colonoscopy colorectal cancers (PCCRC) are found due to incomplete polypectomy…